BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1601384)

  • 1. [Function of oncogenes in neuroepithelial tumors].
    Diedrich U
    Fortschr Neurol Psychiatr; 1992 Apr; 60(4):146-53. PubMed ID: 1601384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
    Burgart LJ; Robinson RA; Haddad SF; Moore SA
    Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration].
    Schwab M
    Klin Padiatr; 1990; 202(4):197-201. PubMed ID: 2203936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue.
    Diedrich U; Soja S; Behnke J; Zoll B
    J Neurol; 1991 Jul; 238(4):221-4. PubMed ID: 1895152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oncogenes, antioncogenes and carcinogenesis].
    Kopnin BP
    Arkh Patol; 1990; 52(9):3-11. PubMed ID: 2270978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
    Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.
    Hollstein MC; Smits AM; Galiana C; Yamasaki H; Bos JL; Mandard A; Partensky C; Montesano R
    Cancer Res; 1988 Sep; 48(18):5119-23. PubMed ID: 3044581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oncogene amplification in human neuroblastomas].
    Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and molecular genetics of nervous system tumors.
    Rey JA; PestaƱa A; Bello MJ
    Oncol Res; 1992; 4(8-9):321-31. PubMed ID: 1336685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
    Kiefer PE; Bepler G; Kubasch M; Havemann K
    Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncogenes and their significance for head and neck cancers].
    Issing WJ; Wustrow TP; Heppt W
    HNO; 1992 Aug; 40(8):283-91. PubMed ID: 1517116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor development and new therapeutic possibilities].
    Dingermann T
    Med Monatsschr Pharm; 1992 Nov; 15(11):322-32. PubMed ID: 1435496
    [No Abstract]   [Full Text] [Related]  

  • 14. Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET.
    Wullich B; Sattler HP; Fischer U; Meese E
    Anticancer Res; 1994; 14(2A):577-9. PubMed ID: 8017863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
    Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
    Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate cancer: cytogenetic and molecular biology principles].
    Strohmeyer T; Effert P
    Med Klin (Munich); 1993 Aug; 88(8):482-4. PubMed ID: 8413050
    [No Abstract]   [Full Text] [Related]  

  • 19. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
    Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
    Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.